MOMENTA PHARMACEUTICALS INC. overview

Johnson & Johnson Completes Acquisition of Momenta Pharmaceuticals, Inc. Acquisition broadens Janssen's leadership in autoimmune diseases and provides a major catalyst for sustained growth PR Newswire NEW BRUNSWICK, N.J., Oct. 1, 2020 NEW BRUNSWICK, N.J. , Oct. 1, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced it has successfully completed its acquisition of Momenta Pharmaceuticals, Inc. ("Momenta"), a company that discovers and develops novel therapies for immune-mediated...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Momenta Pharmaceuticals, Inc. (NasdaqGS: MNTA) to Johnson & Johnson (NYSE: JNJ). Under the terms of the proposed transaction, shareholders of Momenta will receive only $52.50 in cash for each share of Momenta that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the...

SHAREHOLDER ALERT: WeissLaw LLP Investigates Momenta Pharmaceuticals, Inc. PR Newswire NEW YORK, Aug. 19, 2020 NEW YORK , Aug. 19, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Momenta Pharmaceuticals, Inc. ("MNTA" or the "Company") (NASDAQ: MNTA) in connection with the proposed acquisition of the Company by Johnson & Johnson ("JNJ") (NYSE: JNJ). Under the terms of the acquisition agreement, which...

INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Momenta Pharmaceuticals, Inc. - MNTA PR Newswire NEW YORK, Aug. 19, 2020 NEW YORK , Aug. 19, 2020 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating Momenta Pharmaceuticals, Inc. ("MNTA" or the "Company") (Nasdaq: MNTA) relating to its sale to Johnson & Johnson. Under the...

(MNTA) Alert: Johnson Fistel Investigates Proposed Sale of Momenta Pharmaceuticals; Are Shareholders Getting a Fair Price? PR Newswire SAN DIEGO, Aug. 19, 2020 SAN DIEGO , Aug. 19, 2020 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Momenta Pharmaceuticals, Inc. ("Momenta" or the "Company") (NASDAQ: MNTA) breached their fiduciary duties in connection with the proposed sale of the Company to Johnson & Johnson (NYSE:...

Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen's Leadership in Novel Treatments for Autoimmune Diseases $6.5 Billion Acquisition Through an All-Cash Tender Offer of $52.50 Per Momenta Share Lead Asset Nipocalimab Provides Opportunity for Janssen to Deliver Transformative Treatments in Autoantibody-Driven Autoimmune Diseases Momenta's Cambridge, Massachusetts, Presence Increases J&J Footprint and Capabilities in Key Innovation Hub PR Newswire NEW BRUNSWICK, N.J.,...

Thinking about trading options or stock in Momenta Pharmaceuticals, Xerox, Canopy Growth Corp, Apple, or Plug Power? PR Newswire NEW YORK, July 28, 2020 NEW YORK , July 28, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MNTA, XRX, CGC, AAPL, and PLUG. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital...